Daniel Salamon

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ENDOCRINOLOGY. 2023;165(1):bqad174
DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells
Salamon D; Ujvari D; Hellberg A; Hirschberg AL
Article: ONCOIMMUNOLOGY. 2022;11(1):2109861
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+CML stem/progenitor cells potentially through the upregulation of multiple key survival factors
Ujvari D; Malyukova A; Zovko A; Yektaei-Karin E; Madapura HS; Keszei M; Nagy N; Lotfi K; Bjorn N; Wallvik J; Stenke L; Salamon D
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2021;25(20):9523-9532
Interaction between insulin and androgen signalling in decidualization, cell migration and trophoblast invasion in vitro
Hirschberg AL; Jakson I; Graells Brugalla C; Salamon D; Ujvari D
Article: CELL DEATH AND DISEASE. 2021;12(10):875
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells
Malyukova A; Ujvari D; Yektaei-Karin E; Zovko A; Madapura HS; Keszei M; Nagy N; Lotfi K; Bjorn N; Wallvik J; Tamai M; Nguyen TTT; Akahane K; Inukai T; Stenke L; Salamon D
Journal article: HEMATO. 2021;2(1):154-166
Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin
Lasaviciute G; Hoebinger A; Ujvari D; Salamon D; Yusuf A; Sundin M; Sverremark-Ekstroem E; Chikhi R; Nilsson A; Saghafian-Hedengren S
Article: ONCOLOGY REPORTS. 2018;40(2):902-908
Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2018;498(3):502-508
Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells
Ujvari D; Nagy N; Madapura HS; Kallas T; Krohnke MCL; Stenke L; Klein E; Salamon D
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2018;22(1):163-172
Prokineticin 1 is up-regulated by insulin in decidualizing human endometrial stromal cells
Ujvari D; Jakson I; Oldmark C; Attarha S; Alkasalias T; Salamon D; Gidlof S; Hirschberg AL
Article: ONCOGENE. 2017;36(32):4619-4628
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
Madapura HS; Nagy N; Ujvari D; Kallas T; Krohnke MCL; Amu S; Bjorkholm M; Stenke L; Mandal PK; McMurray JS; Keszei M; Westerberg LS; Cheng H; Xue F; Klein G; Klein E; Salamon D
Article: METHODS IN MOLECULAR BIOLOGY. 2017;1532:207-213
Analysis of Viral Epigenotypes Using Bisulfite Sequencing: A Detailed Protocol for the Crucial Bisulfite Modification and PCR Amplification Steps.
Salamon D
Article: PLOS ONE. 2017;12(1):e0171004
Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1
Ujvari D; Jakson I; Babayeva S; Salamon D; Rethi B; Gidlof S; Hirschberg AL
Article: CELL CYCLE. 2016;15(9):1267-1275
cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response
Madapura HS; Salamon D; Wiman KG; Lain S; Klein E; Nagy N
Article: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2016;879:39-69
Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases
Niller HH; Banati F; Salamon D; Minarovits J
Article: JOURNAL OF VIROLOGY. 2014;88(6):3235-3245
T Cells Modulate Epstein-Barr Virus Latency Phenotypes during Infection of Humanized Mice
Heuts F; Rottenberg ME; Salamon D; Rasul E; Adori M; Klein G; Klein E; Nagy N
Article: GENOME RESEARCH. 2014;24(2):177-184
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization
Hansen KD; Sabunciyan S; Langmead B; Nagy N; Curley R; Klein G; Klein E; Salamon D; Feinberg AP
Article: PLOS ONE. 2014;9(8):e106008
The MEC1 and MEC2 Lines Represent Two CLL Subclones in Different Stages of Progression towards Prolymphocytic Leukemia
Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;435(1):8-15
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation
Szenthe K; Koroknai A; Banati F; Bathori Z; Niller HH; Wolf H; Nagy N; Klein E; Minarovits J; Salamon D
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;433(4):489-495
The 5′ regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Article: CELL CYCLE. 2012;11(24):4563-4569
p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP
Madapura HS; Salamon D; Wiman KG; Lain S; Klein G; Klein E; Nagy N
Article: JOURNAL OF VIROLOGY. 2012;86(8):4701-4707
Latency Type-Dependent Modulation of Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Expression by Type I Interferons in B Cells
Salamon D; Adori M; Ujvari D; Wu L; Kis LL; Madapura HS; Nagy N; Klein G; Klein E
Article: CYTOKINE. 2012;57(3):360-371
Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma
Salmon D; Adori M; He M; Bonelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(5):1512-1517
Soluble factors produced by activated CD4⁺ T cells modulate EBV latency
Nagy N; Adori M; Rasul A; Heuts F; Salamon D; Ujvari D; Madapura HS; Leveau B; Klein G; Klein E
Article: BLOOD. 2011;117(1):165-174
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(2):872-877
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter
Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Article: JOURNAL OF GENERAL VIROLOGY. 2009;90(Pt 5):1183-1189
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity
Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
Article: JOURNAL OF GENERAL VIROLOGY. 2008;89(Pt 6):1364-1370
Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus
Fejer G; Koroknai A; Banati F; Gyoery I; Salamon D; Wolf H; Niller HH; Minarovits J
Article: EUROPEAN JOURNAL OF CANCER. 2008;44(7):1030-1038
Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells
Szalmas A; Banati F; Koroknai A; Laszlo B; Feher E; Salamon D; Gergely L; Minarovits J; Konya J
Article: FEBS LETTERS. 2008;582(5):705-709
CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus
Banati F; Koroknai A; Salamon D; Takacs M; Minarovits-Kormuta S; Wolf H; Niller HH; Minarovits J
Article: JOURNAL OF VIROLOGY. 2007;81(23):13242-13247
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells
Gerle B; Koroknai A; Fejer G; Bakos A; Banati F; Szenthe K; Wolf H; Niller HH; Minarovits J; Salamonl D
Article: VIRUS GENES. 2007;35(2):195-202
High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller H; Minarovits J
Article: JOURNAL OF BACTERIOLOGY. 2006;188(19):6932-6942
Rem, a new transcriptional activator of motility and chemotaxis in Sinorhizobium meliloti
Rotter C; Muehlbacher S; Salamon D; Schmitt R; Scharf B
Article: ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA. 2004;51(4):469-484
A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review.
Niller HH; Salamon D; Rahmann S; Ilg K; Koroknai A; Bánáti F; Schwarzmann F; Wolf H; Minárovits J
Article: MEDICAL HYPOTHESES. 2004;62(3):387-391
EBV-associated neoplasms: alternative pathogenetic pathways
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
Article: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES. 2003;111(8):486-490
Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia
Speer G; Tóth M; Niller HH; Salamon D; Takács I; Miheller P; Patócs A; Nagy Z; Bajnok É; Nyiri P; Lakatos P
Journal article: ORVOSI HETILAP. 2003;144(41):2029-2031
[Familial hypocalciuric hypercalcemia].
Tóth M; Speer G; Patócs A; Salamon D; Lakatos P; Rácz K; Tulassay Z
Article: VIRUS GENES. 2003;27(1):57-66
High-resolution methylation analysis and in vivo Protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes
Salamon D; Takacs M; Schwarzmann F; Wolf H; Minarovits J; Niller HH
Article: MEDICAL SCIENCE MONITOR. 2003;9(1):HY1-HY9
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Baeuml G; Ruecker OL; Schwarzmann F; Wolf H; Minarovits J
Article: JOURNAL OF VIROLOGY. 2002;76(8):4113-4118
Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes
Niller HH; Salamon D; Uhlig J; Ranf S; Granz M; Schwarzmann F; Wolf H; Minarovits J
Article: BIOLOGICAL CHEMISTRY. 2001;382(10):1411-1419
Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines
Niller HH; Salamon D; Takacs M; Uhlig J; Wolf H; Minarovits J
Article: BIOLOGICAL CHEMISTRY. 2001;382(4):699-705
Epigenetics of latent Epstein-Barr virus genomes:: High resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes
Takacs M; Salamon D; Myöhänen S; Li H; Segesdi J; Ujvari D; Uhlig J; Niller HH; Wolf H; Berencsi G; Minarovits J
Article: ONCOLOGY. 2000;58(3):242-247
Vitamin D receptor gene Bsml polymorphism correlates with erbB-2/HER-2 expression in human rectal cancer
Speer G; Dworak O; Cseh K; Bori Z; Salamon D; Török I; Winkler G; Vargha P; Nagy Z; Takács I; Kucsera M; Lakatos P
Article: BIOLOGICAL CHEMISTRY. 2000;381(2):95-105
De novo DNA methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes
Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 1998;42(3):169-174
Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in type 2 diabetics and patients with android type obesity
Winkler G; Salamon F; Harmos G; Salamon D; Speer G; Szekeres O; Hajós P; Kovács M; Simon K; Cseh K
Visa fler

Alla övriga publikationer

Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;90(6)
GDF-15 as an alternative survival-factor for antibody-producing cells during chemotherapy
Lasaviciute G; Ujvari D; Salamon D; Eksborg S; Sundin M; Sverremark-Ekstrom E; Nilsson A; Saghafian-Hedengren S
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):270
The influence of chemotherapy on plasma cell survival niche and serological memory
Lasaviciute G; Ujvari D; Salamon D; Eksborg S; Sundin M; Sverremark-Ekstrom E; Saghafian-Hedengren S; Nilsson A
Preprint: PREPRINTS.ORG. 2016
Up-regulation of Lamin A/C Expression in Epstein-Barr Virus Immortalized B Cells and Burkitt Lymphoma Cell Lines of Activated B Cell Phenotype
Bánáti F; Koroknai A; Szenthe K; Tereh T; Kovács N; Hidasi A; Bánkuti B; Buzás K; Lemnitzer F; Ruzsics Z; Szathmary S; Wolf H; Salamon D; Minárovits J; Niller H-H
Conference publication: GYNECOLOGICAL ENDOCRINOLOGY. 2016;32:69
Insulin modulates in vitro decidualization of human endometrial stromal cells via transcriptional inhibition of Forkhead box protein O1 (FOXO1)
Ujvari D; Jakson I; Babayeva S; Salamon D; Rethi B; Gidloef S; Hirschberg AL
Review: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2010;1799(3-4):228-235
Epigenetic regulation of latent Epstein-Barr virus promoters
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Editorial comment: TRENDS IN MICROBIOLOGY. 2004;12(11):495-499
The LCR of EBV makes Burkitt's lymphoma endemic
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Review: JOURNAL OF VIROLOGY. 2001;75(6):2584-2596
Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus
Salamon D; Takacs M; Ujvari D; Uhlig J; Wolf H; Minarovits J; Niller HH
Letter: DIABETOLOGIA. 1998;41(7):860-861
Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity
Winkler G; Salamon E; Salamon D; Speer G; Simon K; Cseh K
Letter: DIABETOLOGIA. 1998;41(4):488
Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus
Winkler G; Dworak O; Salamon F; Salamon D; Speer G; Cseh K
Letter: DIABETES CARE. 1997;20(12):1923-1924
Intimal-medial thickness of the carotid artery in NIDDM patients
Winkler G; Salamon F; Porochnavec M; Solymosi D; Demeter J; Simon K; Salamon D; Karadi I; Cseh K; Romics L

Anställningar

Senior Forskningsspecialist, Kvinnors och barns hälsa, Karolinska Institutet, 2022-

Examina och utbildning

Docent, Cell- och molekylärbiologi, Karolinska Institutet, 2022

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI